Loading clinical trials...
Loading clinical trials...
Thyroid Cancer in Surgically Treated Multinodular Goiter: Incidence and Histopatological Outcomes
This study aims to investigate, based on existing knowledge, the incidence of occult thyroid carcinoma in a cohort of patients with MNG, providing new insights into the prevalence and characteristics of thyroid malignancies in MNG. It seeks to contribute to optimizing diagnostic evaluations for patients with multinodular goiter.
This retrospective study included patients with a preoperative diagnosis of multinodular goiter who underwent total or partial thyroidectomy from January 2018 to May 2024 at the Department of Medical and Surgical Sciences at the University Hospital "Ospedali Riuniti" in Foggia. The study's objective was to investigate the incidence of thyroid carcinoma in patients undergoing thyroidectomy for MNG, also analyzing associated demographic and clinical variables.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
University of Foggia
Foggia, FG, Italy
Start Date
January 1, 2018
Primary Completion Date
May 30, 2024
Completion Date
July 31, 2024
Last Updated
April 11, 2025
223
ACTUAL participants
total or partial thyroidectomy
PROCEDURE
Lead Sponsor
University of Foggia
NCT06316895
NCT07092514
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06558981